Adalgisa Condoluci, MD

Rare Disease / Clinical Research

Oncology Institute of Southern Switzerland

QC-verified· March 2026 PI on 1 trial 1 publication

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Wild type ATTR amyloidosis

Clinical trials (1)

NCT03966105

Verify independently

ClinicalTrials.gov PI search for Adalgisa Condoluci, MD
PubMed author search

Other specialists for Wild type ATTR amyloidosis

Peers ranked by clinical-trial PI role, publications, and verification quality.

Mazen Hanna, MD, M.D
The Cleveland Clinic
OH
Mathew S Maurer, MD
Columbia University
John L Berk, M.D., D.D.S
Boston University
CA
Torstein Hole, MD, PhD
Helse Møre og Romsdal HF and NTNU
Nicolas Verheyen, Res Prof, MD PhD
Medical University of Graz
Jeff Packman, MBA
FoldRx Pharmaceuticals, Inc
MARK MCGOVERN, RN
Eidos Therapeutics, a BridgeBio company
Thibaud DAMY, MD PhD
CHU Henri Mondor, Paris

See all specialists for Wild type ATTR amyloidosis →

← Back to specialists directory